← Back to Search

Behavioral Intervention

Marijuana Education Program for Cannabis Use Disorder

N/A

Recruiting

Research Sponsored by University of Maryland, Baltimore

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 13-35

DSM-5 diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, delusional disorder, other specified schizophrenia spectrum and other psychotic disorder, and unspecified schizophrenia spectrum and other psychotic disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, immediately after the intervention

Awards & highlights

Study Summary

This trial will test a program to help teens with first episode psychosis who also use cannabis heavily. The program will provide education on risks and lower-risk use, and help the teens to maintain their mental health treatment and reduce any harm from cannabis use.

Who is the study for?

This trial is for young people aged 13-35 who are part of a Coordinated Specialty Care program and have been diagnosed with schizophrenia or related disorders. They must have had the illness for less than two years and currently use cannabis. Participants need to be able to understand and agree to join the study.Check my eligibility

What is being tested?

The study is testing an adapted Teen Marijuana Check Up program tailored for those with first episode psychosis who persistently use cannabis. It aims to educate on safer cannabis use, maintain engagement in specialty care, adhere to antipsychotic treatment, and reduce harm from cannabis.See study design

What are the potential side effects?

Since this intervention involves counseling and education rather than medication, typical medical side effects are not expected. However, participants may experience emotional discomfort discussing substance use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 13 and 35 years old.

Select...

I have been diagnosed with a schizophrenia spectrum or other psychotic disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, immediately after the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, immediately after the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Modified Colorado Symptom Index

Timeline Followback

Trial Design

1Treatment groups

Experimental Treatment

Group I: Teen Marijuana Checkup - adaptedExperimental Treatment1 Intervention

Teen Marijuana Checkup will be adapted for youth and young adults with first episode psychosis. The Teen Marijuana Checkup includes two intervention sessions. In Session 1, the interventionist uses motivational interviewing skills to hear the adolescent's history and current concerns with marijuana. The personalized feedback report generated from the baseline assessment is reviewed. In Session 2, the interventionist elicits change talk and guides discussion on making changes to reduce or stop marijuana use.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Teen Marijuana Check Up

2016

N/A

~270

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor

688 Previous Clinical Trials

374,616 Total Patients Enrolled

Media Library

Teen Marijuana Check Up (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04624074 — N/A

Cannabis Use Disorder Research Study Groups: Teen Marijuana Checkup - adapted

Cannabis Use Disorder Clinical Trial 2023: Teen Marijuana Check Up Highlights & Side Effects. Trial Name: NCT04624074 — N/A

Teen Marijuana Check Up (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04624074 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a minimum age threshold for joining this clinical trial?

"This medical trial is available to individuals aged 13-35. For those under the age of 13, there are 81 trials and 143 for patients above 65 years old."

Answered by AI

Are there any vacancies still available in this research program?

"As of now, this medical trial is accepting patients. Initially posted on the first day of 2021, it has seen its most recent update on August 9th 2022 according to clinicaltrials.gov"

Answered by AI

How many participants are contributing to this experiment?

"Affirmative, according to clinicaltrials.gov this investigation is still in need of subjects. It was initially posted on January 1st 2021 and its details were latest modified on August 9th 2022. Forty individuals are needed from a single research centre for the trial to be successful."

Answered by AI

Could I potentially qualify to take part in this clinical research?

"This trial is recruiting 40 individuals aged 13 to 35 who have been diagnosed with a psychotic disorder according to the DSM-5. The required criteria for participation are two years or less of illness, enrollment at a Coordinated Specialty Care program and any one of: schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, delusional disorder or other specified/unspecified schizophrenia spectrum and other psychotic disorders."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pilot Testing the Check Up

Melanie Bennett 2021. "Pilot Testing the Check Up". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04624074.